The Latest Articles

Inside the Dispute Over a High-Profile Psychedelic Study

On April 11, Nature Medicine published a paper about what happened in the brains of people with depression who were treated with either an antidepressant called escitalopram or psilocybin, the active ingredient in magic mushrooms.
ByeditorMay 17, 2022

FDA gives expanded access to MDMA as a treatment for PTSD

Clinics in 10 U.S. cities — including one in Western North Carolina — have been approved by the FDA to expand patient access to MDMA. The recreational drug also known as Ecstasy, will be a treatment for post-traumatic stress disorder.
ByeditorMay 13, 2022

Psychedelic Drugs Market Detailed Study Analysis With Forecast By 2028

2022-05-10 This Psychedelic Drugs Market report makes available statistics on the current state of the industry as a valuable source of guidance and direction for companies and investors interested in…

ByeditorMay 11, 2022

How to Amend the Colonial Expedition for Magic Mushrooms

2022-05-04 The historic tale of conquistador Hernán Cortes’s encounter with Aztec emperor Moctezuma is one often shared to recount the origins of European colonization of the Americas. Moctezuma showed great…

ByeditorMay 5, 2022

Picturesque Ontario healing retreat comes with a magic mushroom trip

A new healing retreat known as “Dimensions Algonquin Highlands” is gearing up to open in Ontario’s hinterland, a three-hour car trip from Toronto. But that’s not the only ‘trip’ involved with this destination.
ByeditorApr 28, 2022

Psilocybin-Assisted Therapy Has Potential for Treatment of Binge Eating Disorder

2022-04-22 In an interview with Pharmacy Times, Jim Gilligan, PhD, interim CEO, president, and chief scientific officer of Tryp Therapeutics, discussed a new trial investigating the potential use of psilocybin-assisted…

ByeditorApr 25, 2022

English English German German